Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Chin J Nat Med ; 18(3): 226-233, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32245593

ABSTRACT

Shenfu injection (SFI), a Chinese medicinal product, shows potent efficacy in treating sepsis. The aim of the present study was to clarify the protective effects of SFI against lipopolysaccharide (LPS)-induced myocardial inflammation and apoptosis. Experiments were carried out in Sprague-Dawley (SD) rats treated with LPS or LPS + SFI, and in H9C2 cardiomyocytes. The sepsis-associated myocardial inflammation and apoptosis was induced by the intraperitoneal injection of LPS (20 mg·kg-1). SFI attenuated the increased expression of tumor necrosis factor (TNF)-α and interleukin (IL)-1ß induced by LPS both in serum and heart. In LPS group, cell viability was reduced, and reversed after SFI administration. LPS treatment increased the expression levels of cleaved-caspase 3 and Bax, and those of Bcl2 and Bcl2/Bax. These two trends were reversed by SFI administration. The expression levels of phosphorylated mitogen-activated protein kinase kinase (p-MEK) and phosphorylated extracellular regulated protein kinases (p-ERK) were increased by LPS, and reversed by SFI. MEK inhibitor U0126 attenuated the apoptosis induced by LPS. These results indicate that SFI could treat LPS-induced cardiac dysfunction. In conclusion, SFI attenuates the inflammation and apoptosis induced by LPS via downregulating the MEK and ERK signaling pathways.


Subject(s)
Apoptosis/drug effects , Drugs, Chinese Herbal/pharmacology , MAP Kinase Signaling System/drug effects , Myocarditis/drug therapy , Myocytes, Cardiac/drug effects , Sepsis/drug therapy , Animals , Caspase 3/metabolism , Interleukin-1beta/metabolism , Lipopolysaccharides , Male , Myocardium/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/metabolism , bcl-2-Associated X Protein/metabolism
2.
Rev Sci Instrum ; 87(6): 064702, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27370477

ABSTRACT

Direct current (DC) electric field is a noninvasive neuromodulation tool that can inhibit or facilitate excitability of neurons. Despite its efficacy, the dielectric constant of artificial cerebrospinal fluid and the position and direction of brain slices and other factors can affect the field intensity and distribution acting on the surface of rat hippocampus slices, thus causing errors. In this study, we describe a new analytical method optimized for DC electric fields acting on brain slices, and the design of an external DC electric field stimulator to allow scientific evaluation of brain slices. We investigated parameters regarding the uniformity of electric field distribution and identified the maximal parameters using the finite element method. Then, we selected and simplified slice images using magnetic resonance imaging data and calculated the electric field intensity of the original and simplified models. The electric field simulator induced action potential and excitatory postsynaptic current with intensities of 1, 5, and 10 V/m. This study describes the development of a new electric field stimulator and successfully demonstrates its practicability for scientific evaluation of tissue slices.


Subject(s)
Action Potentials , Electromagnetic Fields , Hippocampus , Magnetic Resonance Imaging , Synaptic Potentials , Animals , Hippocampus/diagnostic imaging , Hippocampus/physiology , Male , Microdissection , Rats , Rats, Sprague-Dawley
3.
Prostaglandins Other Lipid Mediat ; 82(1-4): 162-74, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17164144

ABSTRACT

Endothelial nitric oxide synthase (eNOS) is a key enzyme in NO-mediated cardiovascular homeostasis and its activity is modulated by a variety of hormonal and mechanical stimuli via phosphorylation modification. Our previous study has demonstrated that epoxyeicosatrienoic acids (EETs), the cytochrome P450 (CYP)-dependent metabolites of arachidonic acid, could robustly up-regulate eNOS expression. However, the molecular mechanism underlying the effects of EETs on eNOS remains elusive. Particularly, whether and how EETs affect eNOS phosphorylation is unknown. In the present study, we investigated the effects of EETs on eNOS phosphorylation with cultured bovine aortic endothelial cells (BAECs). BAECs were either treated with exogenous EETs or infected with recombinant adeno-associated virus (rAAV) carrying CYP2C11-CYPOR, CYP102 F87V mutant and CYP2J2, respectively, to increase endogenous EETs. Both addition of EETs and CYP epoxygenase transfection markedly increased eNOS phosphorylation at its Ser1179 and Thr497 residues. Inhibition of phosphatidylinositol 3-kinase (PI3K) with LY294002 prevented EETs-induced increases of eNOS-Ser(P)1179 but had no effect on the phosphorylation status of Thr497. However, inhibitors of protein kinase B (Akt), mitogen-activated protein kinase (MAPK) and MAPK kinase could block phosphorylation of eNOS at both sites. Inhibition of these kinases also attenuated the up-regulation of eNOS expression by EETs. Finally, administration of viral CYP epoxygenases expression vectors into rats enhanced eNOS phosphorylation and function in vivo. Thus, in addition to up-regulating eNOS expression, EETs also augment eNOS function by enhancing eNOS phosphorylation. EETs-induced up-regulation of eNOS phosphorylation and expression appears to involve in both PI3K/Akt and MAPK pathways.


Subject(s)
8,11,14-Eicosatrienoic Acid/analogs & derivatives , Epoxy Compounds/pharmacology , Nitric Oxide Synthase Type III/metabolism , 8,11,14-Eicosatrienoic Acid/pharmacology , Amino Acid Sequence , Animals , Aorta, Thoracic/cytology , Apigenin/pharmacology , Cattle , Cells, Cultured , Chromones/pharmacology , Cytochrome P-450 CYP2J2 , Cytochrome P-450 Enzyme System/metabolism , Flavonoids/pharmacology , Inositol/analogs & derivatives , Inositol/pharmacology , MAP Kinase Signaling System/drug effects , Male , Morpholines/pharmacology , Nitric Oxide Synthase Type III/immunology , Oxygenases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Phosphothreonine/metabolism , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Rats , Serine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...